Quantum BioPharma Ltd. Adjustments For Decrease Increase In Trade And Other Receivables
Quantum BioPharma Ltd. (QNTM) reported Adjustments For Decrease Increase In Trade And Other Receivables of $196.68 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Notes › Receivables
ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables · last filed 2026-03-26
CAD
| Period end | Adjustments For Decrease Increase In Trade And Other Receivables 12 month |
|---|---|
| 2019-12-31 | -1.08M CAD 40-F/A · filed 2020-03-17 |
| 2018-12-31 | -664.61K CAD 40-F/A · filed 2020-03-17 |
USD
| Period end | Adjustments For Decrease Increase In Trade And Other Receivables 3 month | Adjustments For Decrease Increase In Trade And Other Receivables 6 month | Adjustments For Decrease Increase In Trade And Other Receivables 9 month | Adjustments For Decrease Increase In Trade And Other Receivables 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$99.70K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | $15.20K derived: sum of 2 quarters · filed 2026-03-26 | $97.26K derived: sum of 3 quarters · filed 2026-03-26 | $196.68K 20-F · filed 2026-03-26 |
| 2025-09-30 | $114.90K derived: 6-K 9 month − 6-K 6 month · filed 2025-11-06 | $196.96K derived: sum of 2 quarters · filed 2025-11-06 | $296.38K 6-K · filed 2025-11-06 | $25.90K derived: sum of 4 quarters · filed 2026-03-26 |
| 2025-06-30 | $82.06K derived: 6-K 6 month − 6-K/A 3 month · filed 2025-08-07 | $181.48K 6-K · filed 2025-08-07 | -$88.99K derived: sum of 3 quarters · filed 2026-03-26 | -$106.33K derived: sum of 4 quarters · filed 2026-03-26 |
| 2025-03-31 | $99.42K 6-K/A · filed 2025-06-16 | -$171.06K derived: sum of 2 quarters · filed 2026-03-26 | -$188.39K derived: sum of 3 quarters · filed 2026-03-26 | -$108.69K derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-12-31 | -$270.47K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | -$287.81K derived: sum of 2 quarters · filed 2026-03-26 | -$208.11K derived: sum of 3 quarters · filed 2026-03-26 | -$145.91K 20-F · filed 2026-03-26 |
| 2024-09-30 | -$17.34K derived: 6-K 9 month − 6-K 6 month · filed 2025-11-06 | $62.36K derived: sum of 2 quarters · filed 2025-11-06 | $124.56K 6-K · filed 2025-11-06 | $110.01K derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-06-30 | $79.70K derived: 6-K 6 month − 6-K/A 3 month · filed 2025-08-07 | $141.90K 6-K · filed 2025-08-07 | $127.34K derived: sum of 3 quarters · filed 2026-03-26 | $296.13K derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-03-31 | $62.20K 6-K/A · filed 2025-06-16 | $47.64K derived: sum of 2 quarters · filed 2026-03-26 | $216.43K derived: sum of 3 quarters · filed 2026-03-26 | |
| 2023-12-31 | -$14.55K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | $154.23K derived: sum of 2 quarters · filed 2026-03-26 | $159.59K 20-F · filed 2026-03-26 | |
| 2023-09-30 | $168.79K derived: 6-K 9 month − 6-K/A 6 month · filed 2024-11-12 | $174.14K 6-K · filed 2024-11-12 | ||
| 2023-06-30 | $5.35K 6-K/A · filed 2024-08-19 | |||
| 2022-12-31 | $215.18K 20-F/A · filed 2025-03-31 | |||
| 2021-12-31 | -$106.88K 20-F · filed 2024-04-02 | |||
| 2020-12-31 | $435.18K 20-F · filed 2023-03-31 | |||
| 2019-12-31 | -$387.84K 40-F · filed 2021-03-17 |